Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort.
asthma
infection control
viral infection
Journal
BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
02
09
2020
revised:
28
10
2020
accepted:
16
04
2021
entrez:
6
5
2021
pubmed:
7
5
2021
medline:
18
5
2021
Statut:
ppublish
Résumé
Following the recent COVID-19 lockdown, a reduction in emergency healthcare visits was reported. Infectious diseases were less often diagnosed, while it was not clear if this was due to a decrease in prevalence or a decrease in emergency healthcare visits due to fear of COVID-19. This study comprises a follow-up from a recently finished randomised controlled trial, to gain insight into the prevalence of asthma exacerbation and fear of COVID-19 in patients with moderate-severe asthma and controls in the Netherlands. Participants, patients with asthma and controls, were invited to fill out a short survey by email or post. Exacerbation frequencies until 1 July 2020 were verified with the hospitals' and general practitioners' medical records, pharmacies and patient interviews. In quarter 2 of 2020, mean exacerbation frequency per patient was significantly lower (χ In conclusion, we found a significantly reduced asthma exacerbation frequency during COVID-19 social distancing measures compared with previous years. Patients with asthma also showed more anxiety towards (acquiring) COVID-19 infection. NL8576.
Identifiants
pubmed: 33952584
pii: 8/1/e000758
doi: 10.1136/bmjresp-2020-000758
pmc: PMC8102860
pii:
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Clin Rev Allergy Immunol. 2020 Aug;59(1):78-88
pubmed: 32468411
Allergy. 2021 Mar;76(3):866-868
pubmed: 32479648
Clin Infect Dis. 2013 Feb;56(4):509-16
pubmed: 23087391
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
Allergy. 2020 Oct;75(10):2503-2541
pubmed: 32535955
Can J Neurol Sci. 2020 Sep;47(5):693-696
pubmed: 32450927
J Korean Med Sci. 2020 May 18;35(19):e182
pubmed: 32419400
J Clin Epidemiol. 1994 Jan;47(1):81-7
pubmed: 8283197
J Allergy Clin Immunol. 2020 Jul;146(1):203-206.e3
pubmed: 32333915
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
Psychol Med. 1997 Mar;27(2):363-70
pubmed: 9089829